-
Je něco špatně v tomto záznamu ?
Butyrate, a typical product of gut microbiome, affects function of the AhR gene, being a possible agent of crosstalk between gut microbiome, and hepatic drug metabolism
L. Jourova, E. Anzenbacherova, Z. Dostal, P. Anzenbacher, P. Briolotti, E. Rigal, M. Daujat-Chavanieu, S. Gerbal-Chaloin
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- butyráty * metabolismus farmakologie MeSH
- játra metabolismus MeSH
- kolon metabolismus MeSH
- kyseliny mastné těkavé metabolismus MeSH
- lidé MeSH
- receptory aromatických uhlovodíků genetika metabolismus MeSH
- střevní mikroflóra * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Modulation of gut microbiome composition seems to be a promising therapeutic strategy for a wide range of pathologic states. However, these microbiota-targeted interventions may affect production of microbial metabolites, circulating factors in the gut-liver axis influencing hepatic drug metabolism with possible clinical relevance. Butyrate, a short-chain fatty acid produced through microbial fermentation of dietary fibers in the colon, has well established anti-inflammatory role in the intestine, while the effect of butyrate on the liver is unknown. In this study, we have evaluated the effect of butyrate on hepatic AhR activity and AhR-regulated gene expression. We have showed that AhR and its target genes were upregulated by butyrate in dose-dependent manner in HepG2-C3 as well as in primary human hepatocytes. The involvement of AhR has been proved using specific AhR antagonists and siRNA-mediated AhR silencing. Experiments with AhR reporter cells have shown that butyrate regulates the expression of AhR target genes by modulating the AhR activity. Our results suggest also epigenetic action by butyrate on AhR and its repressor (AHRR) presumably through mechanisms based on HDAC inhibition in the liver. Our results demonstrate that butyrate may influence the drug-metabolizing ability of liver enzymes e.g., through the interaction with AhR-dependent pathways.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22024616
- 003
- CZ-PrNML
- 005
- 20221031101002.0
- 007
- ta
- 008
- 221017s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jnutbio.2022.109042 $2 doi
- 035 __
- $a (PubMed)35533897
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Jourova, Lenka $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic. Electronic address: lenka.jourova@upol.cz
- 245 10
- $a Butyrate, a typical product of gut microbiome, affects function of the AhR gene, being a possible agent of crosstalk between gut microbiome, and hepatic drug metabolism / $c L. Jourova, E. Anzenbacherova, Z. Dostal, P. Anzenbacher, P. Briolotti, E. Rigal, M. Daujat-Chavanieu, S. Gerbal-Chaloin
- 520 9_
- $a Modulation of gut microbiome composition seems to be a promising therapeutic strategy for a wide range of pathologic states. However, these microbiota-targeted interventions may affect production of microbial metabolites, circulating factors in the gut-liver axis influencing hepatic drug metabolism with possible clinical relevance. Butyrate, a short-chain fatty acid produced through microbial fermentation of dietary fibers in the colon, has well established anti-inflammatory role in the intestine, while the effect of butyrate on the liver is unknown. In this study, we have evaluated the effect of butyrate on hepatic AhR activity and AhR-regulated gene expression. We have showed that AhR and its target genes were upregulated by butyrate in dose-dependent manner in HepG2-C3 as well as in primary human hepatocytes. The involvement of AhR has been proved using specific AhR antagonists and siRNA-mediated AhR silencing. Experiments with AhR reporter cells have shown that butyrate regulates the expression of AhR target genes by modulating the AhR activity. Our results suggest also epigenetic action by butyrate on AhR and its repressor (AHRR) presumably through mechanisms based on HDAC inhibition in the liver. Our results demonstrate that butyrate may influence the drug-metabolizing ability of liver enzymes e.g., through the interaction with AhR-dependent pathways.
- 650 12
- $a butyráty $x metabolismus $x farmakologie $7 D002087
- 650 _2
- $a kolon $x metabolismus $7 D003106
- 650 _2
- $a kyseliny mastné těkavé $x metabolismus $7 D005232
- 650 12
- $a střevní mikroflóra $7 D000069196
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a játra $x metabolismus $7 D008099
- 650 _2
- $a receptory aromatických uhlovodíků $x genetika $x metabolismus $7 D018336
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Anzenbacherova, Eva $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Dostal, Zdenek $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Anzenbacher, Pavel $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Briolotti, Philippe $u IRMB, University Montpellier, INSERM, CHU Montpellier, Montpellier, France
- 700 1_
- $a Rigal, Emilie $u IRMB, University Montpellier, INSERM, CHU Montpellier, Montpellier, France
- 700 1_
- $a Daujat-Chavanieu, Martine $u IRMB, University Montpellier, INSERM, CHU Montpellier, Montpellier, France. Electronic address: martine.daujat@inserm.fr
- 700 1_
- $a Gerbal-Chaloin, Sabine $u IRMB, University Montpellier, INSERM, CHU Montpellier, Montpellier, France
- 773 0_
- $w MED00002857 $t Journal of nutritional biochemistry $x 1873-4847 $g Roč. 107, č. - (2022), s. 109042
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35533897 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20221017 $b ABA008
- 991 __
- $a 20221031100959 $b ABA008
- 999 __
- $a ok $b bmc $g 1854381 $s 1175906
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 107 $c - $d 109042 $e 20220507 $i 1873-4847 $m Journal of nutritional biochemistry $n J Nutr Biochem $x MED00002857
- LZP __
- $a Pubmed-20221017